Overview
Lobbying Costs
400,000€ - 499,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2 Fte (4)
Lobbyists with EP accreditation
2
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
BGP Products Operations GmbH – a Viatris Company (Viatris)
EU Transparency Register
940251520152-08 First registered on 04 Jan 2016
Goals / Remit
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance. Our global portfolio includes best-in-class, iconic brand-name products as well as global key brands; generics, including branded and complex generics, and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
Main EU files targeted
EU Pharmaceutical legislation
Paediatric Regulation
EU4Health Programme
Access to Innovation
Industrial Policy
EU Trade Policy
Health Systems Performance Assessment
Health Technology Assessment
Pharmaceuticals in the environment
EU Pharmaceutical Strategy
EU Industrial Strategy
EU Chemical Strategy
Access to Medicines
Medicines Shortages
Antimicrobial Resistance
European Green Deal
Lessons learned from COVID-19
Urban Waste-Water Treatment Directive
Packaging and Packaging Waste Directive
EHDS
EU Global Health StrategyAddress
Head Office
Turmstrasse 24 Tower 4
Steinhausen 6312
SWITZERLANDEU Office
Square de Meeûs, 35 Silversquare Europe
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
4
Employment time Lobbyists 75% 2 25% 2 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 27 Apr 2024
Name Start date End Date Daryl Melissa ALVAREZ VILLAO 17 Feb 2024 14 Feb 2025 Katarina GATIALOVA 29 Feb 2024 28 Feb 2025 Ms Katarina GATIALOVA 29 Feb 2024 15 Apr 2024 Ms Daryl Melissa ALVAREZ VILLAO 17 Feb 2024 15 Apr 2024 Mr David DELANEY 02 Mar 2023 11 Mar 2024 Ms Daryl Melissa ALVAREZ VILLAO 28 Jan 2023 27 Jan 2024 Mr Victor Lino MENDONCA 26 Jan 2023 26 Jan 2024 Ms Katarina GATIALOVA 26 Jan 2023 26 Jan 2024 Ms Katarina GATIALOVA 19 Nov 2021 19 Nov 2022 Mr David DELANEY 13 Oct 2021 13 Oct 2022 Ms Katarina GATIALOVA 06 Feb 2020 06 Feb 2021 Mr Victor Lino MENDONCA 07 Jan 2020 07 Jan 2021 Mr David DELANEY 25 Sep 2019 25 Sep 2020 Ms Katarina GATIALOVA 29 Jan 2019 01 Feb 2020 Mr Victor Lino MENDONCA 30 Nov 2018 30 Nov 2019 Mr David DELANEY 13 Jul 2018 13 Jul 2019 Mr Paulo Jorge RODRIGUES FRANCO MENDES 29 May 2018 31 Oct 2018 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medicines for Europe (MfE) https://www.medicinesforeurope.com/
Amcham EU https://www.amchameu.eu/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
400,000€ - 499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
Name eupportunity zn consulting Closed year Costs
400,000€ - 499,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Viatris EU Twitter account: @ViatrisEUPolicy
Viatris EU Policy website: https://www.viatrispolicy.eu/enOther activities
At European level, Viatris is committed to working in partnership with the institutions of the European Union to support policies and actions that foster positive patient outcomes and high quality medicines for all.
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 05 Jun 2023 Location Brussels Subject Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Zaneta Vegnere (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists - IBM Corporation
- Shopify Inc.
- American Chamber of Commerce to the European Union
- Dow Europe GmbH
- Micron Technology Inc.
- ConocoPhillips
- John Deere GmbH&Co.Kg
- AIG Europe S.A.
- Chamber of Commerce of the United States of America
- AbbVie
- Pharmaceutical Research and Manufacturers of America
- Intel Corporation
- Boeing International Corporation - Belgium Branch Office
- Abbott
- Merck
- Meetings